Back

Polygenic Risk Score Improves Prediction of Primary Open Angle Glaucoma Onset in the Ocular Hypertension Treatment Study

Singh, R.; Zhao, Y.; Elze, T.; Fingert, J.; Gordon, M.; Kass, M. A.; Luo, Y.; Pasquale, L. R.; Scheetz, T.; Segre, A. V.; Wiggs, J. L.; Zebardast, N.

2023-08-16 ophthalmology
10.1101/2023.08.15.23294141
Show abstract

Objective or PurposePrimary open-angle glaucoma (POAG) is a highly heritable disease with 127 identified risk loci. Polygenic risks score (PRS) offers a measure of aggregate genetic burden. In this study, we assess whether PRS improves risk stratification in patients with ocular hypertension. DesignA post-hoc analysis of the Ocular Hypertension Treatment Study (OHTS) data. Setting, Participants, and/or Controls1636 participants were followed from 1994 to 2020 across 22 sites. The PRS was computed for 1009 OHTS participants using summary statistics from largest cross-ancestry POAG metanalysis with weights trained using 8,813,496 variants from 488,395 participants in the UK Biobank. Methods, Interventions, or TestingSurvival regression analysis, with endpoint as development of POAG, predicted disease onset from PRS incorporating baseline covariates. Main Outcomes and MeasuresOutcome measures were hazard ratios for POAG onset. Concordance index and time-dependent AUC were used to compare the predictive performance of multivariable Cox-Proportional Hazards models. ResultsMean PRS was significantly higher for POAG-converters (0.24 {+/-} 0.95) than for non-converters (- 0.12 {+/-} 1.00) (p < 0.01). POAG risk increased 1.36% with each higher PRS decile, with conversion ranging from 9.5% in the lowest PRS decile to 21.8% in the highest decile. Comparison of low-and high-risk PRS tertiles showed a 1.8-fold increase in 20-year POAG risk for participants of European and African ancestries (p<0.01). In the subgroup randomized to delayed treatment, each increase in PRS decile was associated with a 0.52-year decrease in age at diagnosis, (p=0.05). No significant linear relationship between PRS and age at POAG diagnosis was present in the early treatment group. Prediction models significantly improved with the addition of PRS as a covariate (C-index = 0.77) compared to OHTS baseline model (C-index=0.75) (p<0.01). One standard deviation higher PRS conferred a mean hazard ratio of 1.25 (CI=[1.13, 1.44]) for POAG onset. ConclusionsHigher PRS is associated with increased risk for, and earlier development of POAG in patients with ocular hypertension. Early treatment may mitigate the risk from high genetic burden, delaying clinically detectable disease by up to 5.2 years. The inclusion of a PRS improves the prediction of POAG onset.

Matching journals

1
Eye
Springer Science and Business Media LLC · based on 11 published papers
#1
192× avg
2
British Journal of Ophthalmology
BMJ · based on 13 published papers
Top 0.1%
153× avg
3
Translational Vision Science & Technology
Association for Research in Vision and Ophthalmology (ARVO) · based on 18 published papers
Top 0.6%
63× avg
4
Investigative Opthalmology & Visual Science
Association for Research in Vision and Ophthalmology (ARVO) · based on 11 published papers
Top 0.3%
120× avg
5
Ophthalmology Science
Elsevier BV · based on 15 published papers
Top 0.4%
96× avg
6
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 65%
5.6%
7
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 47%
3.1%
8
British Journal of Cancer
Springer Science and Business Media LLC · based on 22 published papers
Top 1%
19× avg
9
Journal of Medical Genetics
BMJ · based on 22 published papers
Top 0.4%
40× avg
10
PLOS Genetics
Public Library of Science (PLoS) · based on 39 published papers
Top 1%
16× avg
11
Nature Communications
Springer Science and Business Media LLC · based on 483 published papers
Top 28%
1.9%
12
Clinical and Translational Science
Wiley · based on 14 published papers
Top 0.7%
21× avg
13
Diabetes, Obesity and Metabolism
Wiley · based on 14 published papers
Top 1%
17× avg
14
Communications Biology
Springer Science and Business Media LLC · based on 36 published papers
Top 2%
8.6× avg
15
Genetics in Medicine
Elsevier BV · based on 57 published papers
Top 4%
3.6× avg
16
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 20%
1.4%
17
Human Genetics
Springer Science and Business Media LLC · based on 14 published papers
Top 0.6%
29× avg
18
Brain
Oxford University Press (OUP) · based on 69 published papers
Top 5%
3.6× avg
19
F1000Research
F1000 Research Ltd · based on 28 published papers
Top 3%
7.1× avg
20
Frontiers in Endocrinology
Frontiers Media SA · based on 20 published papers
Top 3%
5.7× avg
21
Journal of Allergy and Clinical Immunology
Elsevier BV · based on 15 published papers
Top 2%
9.3× avg
22
Cell Reports Medicine
Elsevier BV · based on 49 published papers
Top 6%
3.6× avg